Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
J Psychiatr Res ; 164: 150-161, 2023 08.
Article in English | MEDLINE | ID: mdl-37352811

ABSTRACT

Morphine is one of the most effective and widely used analgesic drugs. However, chronic morphine use caused opioid-induced hyperalgesia (OIH). The development of OIH limits the use of morphine. The mechanisms of OIH are not fully understood. Toll-like receptor4 (TLR4) and glutamate receptors in the periaqueductal gray (PAG) are critical in OIH, however, the association between TLR4 and N-methyl-D-aspartate Receptors (NMDARs) activation in PAG remains unclear. Microglia activation, increased TLR4/p65 nuclear factor-kappa B (p65 NF-κB) and proinflammatory cytokines in microglia, and phosphorylation of NMDAR1 subunit (NR1) and NMDAR2B subunit (NR2B) in neurons were observed in PAG of OIH mice. Up-regulations of TLR4/p65 NF-κB and proinflammatory cytokines (IL-1ß, IL-6, TNF-α) in BV2 cells were prevented by inhibiting and knocking down TLR4. By inhibiting myeloid differentiation factor 2 (MD2) and knocking down the High-mobility group box 1 (HMGB1), we found that morphine activated TLR4 by HMGB1 but not MD2. We co-cultured Neuro-2a (N2A) with BV2 microglial cell line and found that instead of directly phosphorylating NMDAR subunits, morphine increased the phosphorylation of NR1 and NR2B by inducing TLR4-mediated microglia inflammation. Knocking TLR4 out of PAG by Lentivirus-GFP-TLR4 shRNA reversed these changes and relieved OIH. Our findings suggested that the secretion of HMGB1 induced by morphine-activated TLR4 in microglia, and the proinflammatory factors released by activated microglia phosphorylated NR1 and NR2B of adjacent neurons, induced increased neuronal excitability. In conclusion, TLR4/NMDARs in PAG were involved in the development and maintenance of OIH and supported novel strategies for OIH treatment.


Subject(s)
HMGB1 Protein , Morphine , Mice , Animals , Morphine/adverse effects , Morphine/metabolism , Hyperalgesia/chemically induced , Hyperalgesia/metabolism , NF-kappa B/metabolism , Microglia/metabolism , Toll-Like Receptor 4/metabolism , Periaqueductal Gray/metabolism , Signal Transduction , HMGB1 Protein/adverse effects , HMGB1 Protein/metabolism , Inflammation/chemically induced , Inflammation/metabolism , Analgesics, Opioid/adverse effects , Cytokines/metabolism , Neurons
2.
Neurosci Bull ; 39(8): 1210-1228, 2023 Aug.
Article in English | MEDLINE | ID: mdl-36622575

ABSTRACT

The chronic use of morphine and other opioids is associated with opioid-induced hypersensitivity (OIH) and analgesic tolerance. Among the different forms of OIH and tolerance, the opioid receptors and cell types mediating opioid-induced mechanical allodynia and anti-allodynic tolerance remain unresolved. Here we demonstrated that the loss of peripheral µ-opioid receptors (MORs) or MOR-expressing neurons attenuated thermal tolerance, but did not affect the expression and maintenance of morphine-induced mechanical allodynia and anti-allodynic tolerance. To confirm this result, we made dorsal root ganglia-dorsal roots-sagittal spinal cord slice preparations and recorded low-threshold Aß-fiber stimulation-evoked inputs and outputs in superficial dorsal horn neurons. Consistent with the behavioral results, peripheral MOR loss did not prevent the opening of Aß mechanical allodynia pathways in the spinal dorsal horn. Therefore, the peripheral MOR signaling pathway may not be an optimal target for preventing mechanical OIH and analgesic tolerance. Future studies should focus more on central mechanisms.


Subject(s)
Hyperalgesia , Morphine , Humans , Morphine/pharmacology , Hyperalgesia/chemically induced , Hyperalgesia/drug therapy , Hyperalgesia/metabolism , Analgesics, Opioid/pharmacology , Neurons/metabolism , Signal Transduction
3.
Mol Neurobiol ; 60(5): 2553-2571, 2023 May.
Article in English | MEDLINE | ID: mdl-36689134

ABSTRACT

Opioids are often first-line analgesics in pain therapy. However, prolonged use of opioids causes paradoxical pain, termed "opioid-induced hyperalgesia (OIH)." The infralimbic medial prefrontal cortex (IL-mPFC) has been suggested to be critical in inflammatory and neuropathic pain processing through its dynamic output from layer V pyramidal neurons. Whether OIH condition induces excitability changes of these output neurons and what mechanisms underlie these changes remains elusive. Here, with combination of patch-clamp recording, immunohistochemistry, as well as optogenetics, we revealed that IL-mPFC layer V pyramidal neurons exhibited hyperexcitability together with higher input resistance. In line with this, optogenetic and chemogenetic activation of these neurons aggravates behavioral hyperalgesia in male OIH rats. Inhibition of these neurons alleviates hyperalgesia in male OIH rats but exerts an opposite effect in male control rats. Electrophysiological analysis of hyperpolarization-activated cation current (Ih) demonstrated that decreased Ih is a prerequisite for the hyperexcitability of IL-mPFC output neurons. This decreased Ih was accompanied by a decrease in HCN1, but not HCN2, immunolabeling, in these neurons. In contrast, the application of HCN channel blocker increased the hyperalgesia threshold of male OIH rats. Consequently, we identified an HCN-channel-dependent hyperexcitability of IL-mPFC output neurons, which governs the development and maintenance of OIH in male rats.


Subject(s)
Fentanyl , Hyperalgesia , Rats , Male , Animals , Fentanyl/pharmacology , Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels , Pyramidal Cells , Pain
4.
Neuroscience Bulletin ; (6): 1210-1228, 2023.
Article in English | WPRIM (Western Pacific) | ID: wpr-1010607

ABSTRACT

The chronic use of morphine and other opioids is associated with opioid-induced hypersensitivity (OIH) and analgesic tolerance. Among the different forms of OIH and tolerance, the opioid receptors and cell types mediating opioid-induced mechanical allodynia and anti-allodynic tolerance remain unresolved. Here we demonstrated that the loss of peripheral μ-opioid receptors (MORs) or MOR-expressing neurons attenuated thermal tolerance, but did not affect the expression and maintenance of morphine-induced mechanical allodynia and anti-allodynic tolerance. To confirm this result, we made dorsal root ganglia-dorsal roots-sagittal spinal cord slice preparations and recorded low-threshold Aβ-fiber stimulation-evoked inputs and outputs in superficial dorsal horn neurons. Consistent with the behavioral results, peripheral MOR loss did not prevent the opening of Aβ mechanical allodynia pathways in the spinal dorsal horn. Therefore, the peripheral MOR signaling pathway may not be an optimal target for preventing mechanical OIH and analgesic tolerance. Future studies should focus more on central mechanisms.


Subject(s)
Humans , Morphine/pharmacology , Hyperalgesia/metabolism , Analgesics, Opioid/pharmacology , Neurons/metabolism , Signal Transduction
5.
Biomed Pharmacother ; 139: 111653, 2021 Jul.
Article in English | MEDLINE | ID: mdl-34243625

ABSTRACT

The clinical application of opioids may be accompanied by a series of adverse consequences, such as opioid tolerance, opioid-induced hyperalgesia, opioid dependence or addiction. In view of this issue, clinicians are faced with the dilemma of treating various types of pain with or without opioids. In this review, we discuss that Src protein tyrosine kinase plays an important role in these adverse consequences, and Src inhibitors can solve these problems well. Therefore, Src inhibitors have the potential to be used in combination with opioids to achieve synergy. How to combine them together to maximize the analgesic effect while avoiding unnecessary trouble provides a topic for follow-up research.


Subject(s)
Analgesics, Opioid/pharmacology , Chronic Pain/drug therapy , Drug Tolerance/physiology , Hyperalgesia/chemically induced , Protein Kinase Inhibitors/pharmacology , Substance-Related Disorders/etiology , src-Family Kinases/antagonists & inhibitors , Analgesics, Opioid/metabolism , Animals , Chronic Pain/metabolism , Humans , Hyperalgesia/metabolism
6.
J Neurosci ; 39(36): 7061-7073, 2019 09 04.
Article in English | MEDLINE | ID: mdl-31300521

ABSTRACT

Opioid-induced hyperalgesia (OIH) is a serious adverse event produced by opioid analgesics. Lack of an in vitro model has hindered study of its underlying mechanisms. Recent evidence has implicated a role of nociceptors in OIH. To investigate the cellular and molecular mechanisms of OIH in nociceptors, in vitro, subcutaneous administration of an analgesic dose of fentanyl (30 µg/kg, s.c.) was performed in vivo in male rats. Two days later, when fentanyl was administered intradermally (1 µg, i.d.), in the vicinity of peripheral nociceptor terminals, it produced mechanical hyperalgesia (OIH). Additionally, 2 d after systemic fentanyl, rats had also developed hyperalgesic priming (opioid-primed rats), long-lasting nociceptor neuroplasticity manifested as prolongation of prostaglandin E2 (PGE2) hyperalgesia. OIH was reversed, in vivo, by intrathecal administration of cordycepin, a protein translation inhibitor that reverses priming. When fentanyl (0.5 nm) was applied to dorsal root ganglion (DRG) neurons, cultured from opioid-primed rats, it induced a µ-opioid receptor (MOR)-dependent increase in [Ca2+]i in 26% of small-diameter neurons and significantly sensitized (decreased action potential rheobase) weakly IB4+ and IB4- neurons. This sensitizing effect of fentanyl was reversed in weakly IB4+ DRG neurons cultured from opioid-primed rats after in vivo treatment with cordycepin, to reverse of OIH. Thus, in vivo administration of fentanyl induces nociceptor neuroplasticity, which persists in culture, providing evidence for the role of nociceptor MOR-mediated calcium signaling and peripheral protein translation, in the weakly IB4-binding population of nociceptors, in OIH.SIGNIFICANCE STATEMENT Clinically used µ-opioid receptor agonists such as fentanyl can produce hyperalgesia and hyperalgesic priming. We report on an in vitro model of nociceptor neuroplasticity mediating this opioid-induced hyperalgesia (OIH) and priming induced by fentanyl. Using this model, we have found qualitative and quantitative differences between cultured nociceptors from opioid-naive and opioid-primed animals, and provide evidence for the important role of nociceptor µ-opioid receptor-mediated calcium signaling and peripheral protein translation in the weakly IB4-binding population of nociceptors in OIH. These findings provide information useful for the design of therapeutic strategies to alleviate OIH, a serious adverse event of opioid analgesics.


Subject(s)
Analgesics, Opioid/toxicity , Fentanyl/toxicity , Hyperalgesia/physiopathology , Neuronal Plasticity , Nociceptors/drug effects , Action Potentials , Animals , Calcium Signaling , Ganglia, Spinal/cytology , Hyperalgesia/etiology , Hyperalgesia/metabolism , Male , Nociceptors/metabolism , Nociceptors/physiology , Rats , Rats, Sprague-Dawley , Receptors, Opioid/metabolism
7.
J Neurosci ; 39(33): 6414-6424, 2019 08 14.
Article in English | MEDLINE | ID: mdl-31209174

ABSTRACT

In addition to analgesia, opioids produce opioid-induced hyperalgesia (OIH) and neuroplasticity characterized by prolongation of inflammatory-mediator-induced hyperalgesia (hyperalgesic priming). We evaluated the hypothesis that hyperalgesia and priming induced by opioids are mediated by similar nociceptor mechanisms. In male rats, we first evaluated the role of nociceptor Toll-like receptor 4 (TLR4) in OIH and priming induced by systemic low-dose morphine (LDM, 0.03 mg/kg). Intrathecal oligodeoxynucleotide antisense to TLR4 mRNA (TLR4 AS-ODN) prevented OIH and prolongation of prostaglandin E2 hyperalgesia (priming) induced by LDM. In contrast, high-dose morphine (HDM, 3 mg/kg) increased nociceptive threshold (analgesia) and induced priming, neither of which was attenuated by TLR4 AS-ODN. Protein kinase C ε (PKCε) AS-ODN also prevented LDM-induced hyperalgesia and priming, whereas analgesia and priming induced by HDM were unaffected. Treatment with isolectin B4 (IB4)-saporin or SSP-saporin (which deplete IB4+ and peptidergic nociceptors, respectively), or their combination, prevented systemic LDM-induced hyperalgesia, but not priming. HDM-induced priming, but not analgesia, was markedly attenuated in both saporin-treated groups. In conclusion, whereas OIH and priming induced by LDM share receptor and second messenger mechanisms in common, action at TLR4 and signaling via PKCε, HDM-induced analgesia, and priming are neither TLR4 nor PKCε dependent. OIH produced by LDM is mediated by both IB4+ and peptidergic nociceptors, whereas priming is not dependent on the same population. In contrast, priming induced by HDM is mediated by both IB4+ and peptidergic nociceptors. Implications for the use of low-dose opioids combined with nonopioid analgesics and in the treatment of opioid use disorder are discussed.SIGNIFICANCE STATEMENT Opioid-induced hyperalgesia (OIH) and priming are common side effects of opioid agonists such as morphine, which acts at µ-opioid receptors. We demonstrate that OIH and priming induced by systemic low-dose morphine (LDM) share action at Toll-like receptor 4 (TLR4) and signaling via protein kinase C ε (PKCε) in common, whereas systemic high-dose morphine (HDM)-induced analgesia and priming are neither TLR4 nor PKCε dependent. OIH produced by systemic LDM is mediated by isolectin B4-positive (IB4+) and peptidergic nociceptors, whereas priming is dependent on a different class of nociceptors. Priming induced by systemic HDM is, however, mediated by both IB4+ and peptidergic nociceptors. Our findings may provide useful information for the use of low-dose opioids combined with nonopioid analgesics to treat pain and opioid use disorders.


Subject(s)
Analgesics, Opioid/pharmacology , Hyperalgesia/metabolism , Morphine/pharmacology , Signal Transduction/drug effects , Toll-Like Receptor 4/metabolism , Animals , Hyperalgesia/chemically induced , Male , Neuronal Plasticity/drug effects , Rats , Rats, Sprague-Dawley
8.
Neurosurg Focus ; 46(4): E8, 2019 04 01.
Article in English | MEDLINE | ID: mdl-30933925

ABSTRACT

OBJECTIVEEnhanced recovery after surgery (ERAS) and multimodal analgesia are established care models that minimize perioperative opioid consumption and promote positive outcomes after spine surgery. Opioid-free anesthesia (OFA) is an emerging technique that may achieve similar goals. The purpose of this study was to evaluate an OFA regimen within an ERAS pathway for lumbar decompressive surgery and to compare perioperative opioid requirements in a matched cohort of patients managed with traditional opioid-containing anesthesia (OCA).METHODSThe authors performed a retrospective analysis of prospectively collected data. They included 36 patients who underwent lumbar decompression under their ERAS pathway for spinal decompression between February and August 2018. Eighteen patients who received OFA were matched in a 1:1 ratio to a cohort managed with a traditional OCA regimen. The primary outcome was total perioperative opioid consumption. Postoperative pain scores (measured using the numerical rating scale [NRS]), opioid consumption (total morphine equivalents), and length of stay (time to readiness for discharge) were compared in the postanesthesia care unit (PACU). The authors also assessed compliance with ERAS process measures and compared compliance during 3 phases of care: pre-, intra-, and postoperative.RESULTSThere was a significant reduction in total perioperative opioid consumption in patients who received OFA (2.43 ± 0.86 oral morphine equivalents [OMEs]; mean ± SEM), compared to patients who received OCA (38.125 ± 6.11 OMEs). There were no significant differences in worst postoperative pain scores (NRS scores 2.55 ± 0.70 vs 2.58 ± 0.73) or opioid consumption (5.28 ± 1.7 vs 4.86 ± 1.5 OMEs) in the PACU between OFA and OCA groups, respectively. There was a clinically significant decrease in time to readiness for discharge from the PACU associated with OFA (37 minutes), although this was not statistically significantly different. The authors found high overall compliance with ERAS process measures (91.4%) but variation in compliance according to phase of care. The highest compliance occurred during the preoperative phase (94.71% ± 2.88%), and the lowest compliance occurred during the postoperative phase of care (85.4% ± 5.7%).CONCLUSIONSOFA within an ERAS pathway for lumbar spinal decompression represents an opportunity to minimize perioperative opioid exposure without adversely affecting pain control or recovery. This study reveals opportunities for patient and provider education to reinforce ERAS and highlights the postoperative phase of care as a time when resources should be focused to increase ERAS adherence.


Subject(s)
Analgesics, Opioid , Anesthesia/methods , Enhanced Recovery After Surgery , Lumbar Vertebrae/surgery , Minimally Invasive Surgical Procedures/methods , Neurosurgical Procedures/methods , Adult , Aged , Aged, 80 and over , Anesthesia Recovery Period , Cohort Studies , Decompression, Surgical/methods , Female , Guideline Adherence/statistics & numerical data , Humans , Length of Stay , Male , Middle Aged , Pain, Postoperative/drug therapy , Pain, Postoperative/epidemiology , Postoperative Care , Retrospective Studies , Treatment Outcome
10.
Neuroscience ; 394: 60-71, 2018 12 01.
Article in English | MEDLINE | ID: mdl-30342200

ABSTRACT

Stimulation of the mu-opioid receptor (MOR) on nociceptors with fentanyl can produce hyperalgesia (opioid-induced hyperalgesia, OIH) and hyperalgesic priming, a model of transition to chronic pain. We investigated if local and systemic administration of biased MOR agonists (PZM21 and TRV130 [oliceridine]), which preferentially activate G-protein over ß-arrestin translocation, and have been reported to minimize some opioid side effects, also produces OIH and priming. Injected intradermally (100 ng), both biased agonists induced mechanical hyperalgesia and, when injected at the same site, 5 days later, prostaglandin E2 (PGE2) produced prolonged hyperalgesia (priming). OIH and priming were both prevented by intrathecal treatment with an oligodeoxynucleotide (ODN) antisense (AS) for MOR mRNA. Agents that reverse Type I (the protein translation inhibitor cordycepin) and Type II (combination of Src and mitogen-activated protein kinase [MAPK] inhibitors) priming, or their combination, did not reverse priming induced by local administration of PZM21 or TRV130. While systemic PZM21 at higher doses (1 and 10 mg/kg) induced analgesia, lower doses (0.001, 0.01, 0.1, and 0.3 mg/kg) induced hyperalgesia; all doses induced priming. Hyperalgesia, analgesia and priming induced by systemic administration of PZM21 were also prevented by MOR AS-ODN. And, priming induced by systemic PZM21 was also not reversed by intradermal cordycepin or the combination of Src and MAPK inhibitors. Thus, maintenance of priming induced by biased MOR agonists, in the peripheral terminal of nociceptors, has a novel mechanism.


Subject(s)
Analgesics, Opioid/administration & dosage , Hyperalgesia/chemically induced , Receptors, Opioid, mu/agonists , Spiro Compounds/administration & dosage , Thiophenes/administration & dosage , Urea/analogs & derivatives , Animals , Dinoprostone/administration & dosage , Dose-Response Relationship, Drug , Injections, Intradermal , Male , Nociception/drug effects , Pain Threshold , Rats, Sprague-Dawley , Urea/administration & dosage
11.
Curr Radiopharm ; 11(1): 58-63, 2018.
Article in English | MEDLINE | ID: mdl-29437030

ABSTRACT

BACKGROUND: Para-18F-fluorohippuric acid (18F-PFH) and ortho-124I-iodohippuric acid (124IOIH) were recently identified as potential radiotracers suitable for conducting renography using positron emission tomography (PET). The aim of this work was to estimate preliminary human-equivalent internal radiation dose of 18F-PFH and 124I-OIH using the biodistribution data reported in healthy rats. The results were compared with the absorbed dose data of technetium-99m-mercaptoacetyltriglycine (99mTc- MAG3) as documented in the International Commission on Radiological Protection (ICRP) publication 80. METHODS: The medical internal radiation dose (MIRD) formula was applied to extrapolate data from rats to human and to project the absorbed radiation dose for various organs in humans. S factor was calculated by Monte-Carlo N-particle (MCNP) simulation. RESULTS: Our dose prediction shows that an injection of 18F-PFH or 124I-OIH in humans would result in an estimated effective absorbed dose of 0.09 or 0.17 µSv/MBq respectively for whole body, which is about 135 or 73 times respectively lower than that obtained with an injection of 99mTc-MAG3. All organs except kidneys would receive an estimated effective absorbed dose of <0.1 µSv/MBq for 18F-PFH or 124I-OIH. Kidneys would receive a dose of 0.83 or 0.77 µSv/MBq respectively for 18F-PFH or 124I-OIH. CONCLUSIONS: Our results indicate that 18F-PFH and 124I-OIH would deliver much safer levels and lower radiation doses to the patients compared to 99mTc-MAG3 and warrants a clinical trial to estimate the radiation doses more accurately.


Subject(s)
Hippurates , Iodohippuric Acid , Positron-Emission Tomography , Radiation Dosage , Radioisotope Renography/methods , Animals , Fluorine Radioisotopes , Humans , Iodine Radioisotopes , Monte Carlo Method , Rats , Renal Agents , Technetium Tc 99m Mertiatide , Tissue Distribution
12.
J Comput Chem ; 39(10): 527-534, 2018 Apr 15.
Article in English | MEDLINE | ID: mdl-29114892

ABSTRACT

Density functional theory computations with the B3LYP/6-311++G(2df,2p) method and IR spectroscopy are employed in investigating the properties of twenty π-hydrogen bonded complexes between substituted phenols and hexamethylbenzene. All complexes possess T-shaped structures. The methyl hyperconjugative effects on interactions energies and OH stretching frequencies are estimated via comparisons with previously reported theoretical and experimental results for analogous phenol complexes with benzene. The theoretical computations provide excellent quantitative predictions of the OH stretching frequency shifts (ΔνOH ) resulting from the hydrogen bonding. The ΔνOH shifts in the hexamethylbenzene complexes are approximately twice as large as the corresponding shifts for the benzene complexes. Hirshfeld charges, electrostatic potential at nuclei values, and molecular electrostatic potential maps are employed in gaining insights into the mechanisms of methyl hyperconjugative effects on complex formation. © 2017 Wiley Periodicals, Inc.

13.
Appl Radiat Isot ; 115: 251-255, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27434486

ABSTRACT

Ortho-[(131)I]iodohippurate [(131)I]OIH (marketed as Hippuran I 131), a gold standard for radionuclide renography, and [(123)I]OIH were in clinical use for decades. Here we radiolabeled OIH with (124)I (a positron emitter) to combine the desirable biological properties of OIH and to enable the use of positron emission tomography (PET) for renography. [(124)I]OIH was synthesized with a slight modification to a previously reported method for the kit preparation of [(123)I]OIH based on the Cu(II) catalyzed isotope-exchange reaction. Our method utilized heating at 120°C under sealed condition in a heating block instead of autoclaving. [(124)I]OIH was obtained with a radiochemical purity of >99.3%, radiochemical yield of 94.5%, and specific activity of ~17 MBq/mg. Biodistribution studies in healthy Sprague Dawley rats revealed results comparable to that of [(131)I]OIH as reported in the literature. The PET-derived [(124)I]OIH renograms revealed an average time-to-peak of 2.8±0.4min and the average time-to-half-maximal activity of 11.4±1.5min, which are also comparable to that of [(131)I]OIH as reported in the literature. Results from this study indicate that the synthesis of [(124)I]OIH without using an autoclave and [(124)I]OIH PET renography are feasible.


Subject(s)
Iodohippuric Acid , Kidney/diagnostic imaging , Radioisotope Renography , Animals , Rats , Rats, Sprague-Dawley , Tissue Distribution
14.
Angew Chem Int Ed Engl ; 54(40): 11861-4, 2015 Sep 28.
Article in English | MEDLINE | ID: mdl-26277446

ABSTRACT

Mechanistic insight into the homolytic cleavage of the O-H bond of water by the heteronuclear oxide cluster [Ga2 Mg2 O5 ](.+) has been derived from state-of-the-art gas-phase experiments in conjunction with quantum chemical calculations. Three pathways have been identified computationally. In addition to the conventional hydrogen-atom transfer (HAT) to the radical center of a bridging oxygen atom, two mechanistically distinct proton-coupled electron-transfer (PCET) processes have been identified. The energetically most favored path involves initial coordination of the incoming water ligand to a magnesium atom followed by an intramolecular proton transfer to the lone-pair of the bridging oxygen atom. This step, which is accomplished by an electronic reorganization, generates two structurally equivalent OH groups either of which can be liberated, in agreement with labeling experiments.

15.
Angew Chem Int Ed Engl ; 53(51): 14230-4, 2014 Dec 15.
Article in English | MEDLINE | ID: mdl-25313894

ABSTRACT

Oxetanes offer exciting potential as structural motifs and intermediates in drug discovery and materials science. Here an efficient strategy for the synthesis of oxetane rings incorporating pendant functional groups is described. A wide variety of oxetane 2,2-dicarboxylates were accessed in high yields, including functionalized 3-/4-aryl- and alkyl-substituted oxetanes and fused oxetane bicycles. Enantioenriched alcohols provided enantioenriched oxetanes with complete retention of configuration. The oxetane products were further derivatized, while the ring was maintained intact, thus highlighting their potential as building blocks for medicinal chemistry.

16.
Korean Journal of Urology ; : 835-842, 1995.
Article in Korean | WPRIM (Western Pacific) | ID: wpr-224819

ABSTRACT

To investigate the efficacy of Tc-99m MAG3 for renal scan, the images and renograms of Tc-99m MAG3 were compared to those of I-131 hippuran. Tc-99m MAG3 diuretic renal scan and I-131 hippuran diuretic renal scan were undertaken in 16 children with upper urinary tract anomalies within the time interval of 2 to 3 days. Their ages ranged from 1 week to 11 years old, and the male-to-female ratio was 14 to 2. Of these patients, 9 patients were less than 1 year old. The spectrum of upper urinary tract anomalies were unilateral ureteropelvic junction obstruction in 7 cases, bilateral ureteropelvic junction obstruction in 5 cases, bilateral non-obstructing non-refluxing megaureter, unilateral non-obstructing non-refluxing megaureter, bilateral obstructing megaureter and unilateral ulticystic dysplastic kidney in 1 case respectively. The images of Tc-99m MAG3 showed better resolution than those of I- 131 hippuran. The parameters of the Tc-99m MAG3 renogram in total functioning renal units, such as time to peak renal activity(r=0.98), half-time clearance to peak(r=0.88), half-time clearance after diuretic injection(r=0.96) and relative renal function(r=0.90), were correlated well with those of I-131 hippuran. In conclusion, Tc-99m MAG3 diuretic renal scan is considered to have a high potential to replace I-131 hippuran in routine radionuclide renal studies as well as renal tubular function test.


Subject(s)
Child , Humans , Kidney , Urinary Tract
17.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-535321

ABSTRACT

0. 5) in the patients with nephritis, uretericcalculi and other diseases. The renogram methodis simple, inexpensive, without blood samplingand is useful in clinical application.

SELECTION OF CITATIONS
SEARCH DETAIL
...